Crestor
Rosuvastatin
- Strength
- 5 mg/1
- Form
- Tablet, Film Coated
- Class
- HMG-CoA Reductase Inhibitor
AstraZeneca Pharmaceuticals LP
Rosuvastatin Calcium
Listed by Rising Pharma Holdings, Inc.
- Strength
- 40 mg/1
- Form
- Tablet, Film Coated
- Route
- Oral
- Class
- HMG-CoA Reductase Inhibitor
What it contains
- Rosuvastatin Calcium 40 mg/1
FDA record
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | HMG-CoA Reductase Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 57237-171 |
| FDA application | ANDA079170 |
| RxNorm concept | 859419 |
| Package sizes listed | 4 |
| Marketed since | July 2016 |
Other products containing Rosuvastatin
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Crestor
Rosuvastatin
- Strength
- 40 mg/1
- Form
- Tablet, Film Coated
- Class
- HMG-CoA Reductase Inhibitor
AstraZeneca Pharmaceuticals LP
Crestor
Rosuvastatin
- Strength
- 20 mg/1
- Form
- Tablet, Film Coated
- Class
- HMG-CoA Reductase Inhibitor
AstraZeneca Pharmaceuticals LP
Crestor
Rosuvastatin
- Strength
- 10 mg/1
- Form
- Tablet, Film Coated
- Class
- HMG-CoA Reductase Inhibitor
AstraZeneca Pharmaceuticals LP
Rosuvastain Calcium
- Strength
- 10 mg/1
- Form
- Tablet, Film Coated
- Class
- HMG-CoA Reductase Inhibitor
Chartwell RX, LLC
Rosuvastain Calcium
- Strength
- 40 mg/1
- Form
- Tablet, Film Coated
- Class
- HMG-CoA Reductase Inhibitor
Chartwell RX, LLC
Rosuvastain Calcium
- Strength
- 20 mg/1
- Form
- Tablet, Film Coated
- Class
- HMG-CoA Reductase Inhibitor
Chartwell RX, LLC
Rosuvastain Calcium
- Strength
- 5 mg/1
- Form
- Tablet, Film Coated
- Class
- HMG-CoA Reductase Inhibitor
Chartwell RX, LLC
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.